Web of Science: 0 cites, Scopus: 0 cites, Google Scholar: cites,
Association of Liver Damage and Quasispecies Maturity in Chronic HCV Patients : The Fate of a Quasispecies
Gregori i Font, Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Ibañez Lligoña, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Colomer-Castell, Sergi (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Campos, Carolina (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Garcia-Cehic, D (University of Cincinnati)
Quer, Josep 1963- (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)

Data: 2024
Resum: Viral diversity and disease progression in chronic infections, and particularly how quasispecies structure affects antiviral treatment, remain key unresolved issues. Previous studies show that advanced liver fibrosis in long-term viral infections is linked to higher rates of antiviral treatment failures. Additionally, treatment failure is associated with high quasispecies fitness, which indicates greater viral diversity and adaptability. As a result, resistant variants may emerge, reducing retreatment effectiveness and increasing the chances of viral relapse. Additionally, using a mutagenic agent in monotherapy can accelerate virus evolution towards a flat-like quasispecies structure. This study examines 19 chronic HCV patients who failed direct-acting antiviral (DAA) treatments, using NGS to analyze quasispecies structure in relation to fibrosis as a marker of infection duration. Results show that HCV evolves towards a flat-like quasispecies structure over time, leading also to advanced liver damage (fibrosis F3 and F4/cirrhosis). Based on our findings and previous research, we propose that the flat-like fitness quasispecies structure is the final stage of any quasispecies in chronic infections unless eradicated. The longer the infection persists, the lower the chances of achieving a cure. Interestingly, this finding may also be applicable to other chronic infection and drug resistance in cancer.
Ajuts: Instituto de Salud Carlos III PI22/00258
Ministerio de Educación FPU21/04150
"la Caixa" Foundation LCF/BQ/DR23/12000020
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article ; recerca ; Versió publicada
Matèria: Quasispecies diversity ; Quasispecies maturity ; Quasispecies fitness ; Fibrosis ; Liver damage ; Antiviral treatment failure
Publicat a: Microorganisms, Vol. 12, Núm. 11 (October 2024) , ISSN 2076-2607

DOI: 10.3390/microorganisms12112213
PMID: 39597607


15 p, 1.7 MB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2024-12-04, darrera modificació el 2025-02-06



   Favorit i Compartir